Clinical Trial Update: Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update evaluates lenalidomide in previously treated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Georg Aue, M.D. | Conditions: Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-01-13